Site Map  Contact      Deutsch                                    Order Service  Financial Publications  Downloads

Linde Gas Therapeutics
Our Healthcare division operates as a pharmaceutical gas company, filling the gap that exists between the pure medical and industrial gas segments. Consistent with our aspirations and by virtue of our broad international presence, we offer our medical expertise in the emerging countries as well.

Linde’s Healthcare operations embrace three sectors, namely Institutional (hospitals, doctors and rescue services), Respiratory Homecare (outpatients) and INO Therapeutics (intensive care). Our research concentrates on drug and device combinations for the respiratory system in the intensive care setting. Linde also supports the GEMI Fund, an organization devoted to stimulating research into medical applications for gas. (For detailed information on the GEMI Fund, see the section “Healthcare” in the "Society" chapter)

São Paulo, Brazil
People with good health are fortunate. But with Linde, they don’t have to be privileged. Longer life expectancies inevitably mean an increased susceptibility to illness. This places a huge financial burden on healthcare systems, particularly in the emerging economies. Linde Gas Therapeutics has developed solutions for treating patients with respiratory ailments at home. Of obvious benefit to patients, they also reduce the cost of treatment.

We are untiring in our efforts to offer users better and safer treatment methods based on medical gases. Our representatives are available to train and advise medical staff on site. We are also active in emerging nations such as those in South America, where we are a leading provider and generate more than ten percent of our Healthcare sales. We contribute to the further development of these countries by raising the standard of care and facilitating knowledge transfer.

In order to ensure maximum safety for patients, we operate a seamless quality control regime from the production facility to the place of application. We also document the safety and efficacy of our products in accordance with the applicable regulatory guidelines. In the event of new medical gas therapies, the pre-clinical and clinical documentation complies with the customary development directives for pharmaceutical products.


Keywords

Please select: